Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Gene Writing: New Tech to Correct Disease

Gene Writing: New Tech to Correct Disease

FromTalking Biotech with Dr. Kevin Folta


Gene Writing: New Tech to Correct Disease

FromTalking Biotech with Dr. Kevin Folta

ratings:
Length:
46 minutes
Released:
Nov 14, 2020
Format:
Podcast episode

Description

Gene editing is a relatively new technology that has revolutionary applications in agriculture and medicine.  The drawback to the technology is that it typically can only be used to disrupt a deleterious gene underlying a specific trait.  Gene writing exploits a natural process in cells that allows researchers to install genes of interest, allowing replacement of damaged sequences that lead to negative health outcomes.  Dr. Geoff von Maltzahn of Tessera describes what the new technology is and its most likely applications, particularly in the area of correcting genetic disease. Twitter:  Tessera @TesseraTx Dr. Geoffrey von Maltzahn;  @GVMaltzahn# COLABRATalking Biotech is brought to you by Colabra – an R&D platform that brings your lab’s world-changing research together in one shared space. Learn more at https://www.colabra.app/# TALKING BIOTECHTwitter: https://twitter.com/talkingbiotechWebsite: https://www.colabra.app/podcasts/talking-biotech/Instagram: https://www.instagram.com/colabrahqThe Talking Biotech podcast is distinct from Dr. Kevin Folta's teaching and research roles at the University of Florida. The views expressed on the show are those of Dr. Folta and his guests, and do not reflect the opinions of the university or Colabra.
Released:
Nov 14, 2020
Format:
Podcast episode

Titles in the series (100)

Talking Biotech is a weekly podcast that uncovers the stories, ideas and research of people at the frontier of biology and engineering. Each episode explores how science and technology will transform agriculture, protect the environment, and feed 10 billion people by 2050. Interviews are led by Dr. Kevin Folta, a professor of molecular biology and genomics.